MultiCell MCET Stock
MultiCell Price Chart
MultiCell MCET Financial and Trading Overview
| MultiCell stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 15.8K USD |
| Avg. Volume | 0 USD |
| Market Cap | 10K USD |
| Beta (5Y Monthly) | -10.006338 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MCET Valuation Measures
| Enterprise Value | -1001874 USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.012419961 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | -1.244 |
| Enterprise Value/EBITDA | N/A |
Trading Information
MultiCell Stock Price History
| Beta (5Y Monthly) | -10.006338 |
| 52-Week Change | 900.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 9.82E-5 USD |
MCET Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 5B |
| Float | 4.5B |
| Short Ratio | N/A |
| % Held by Insiders | 9.99% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2014 |
| Most Recent Quarter (mrq) | August 31, 2015 |
| Next Fiscal Year End | November 30, 2015 |
Profitability
| Profit Margin | -31.49% |
| Operating Margin (ttm) | -59.60% |
| Gross Margin | 73.06% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -136.36% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 805.24K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 1479.79% |
| Gross Profit (ttm) | 49.32K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -253605 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 281.12K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 149.08K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.192 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -196892 USD |
| Levered Free Cash Flow (ttm) | -179898 USD |
Profile of MultiCell
| Country | United States |
| State | RI |
| City | Woonsocket |
| Address | 68 Cumberland Street |
| ZIP | 02895 |
| Phone | 401-762-0045 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Q&A For MultiCell Stock
What is a current MCET stock price?
MultiCell MCET stock price today per share is 0.0001 USD.
How to purchase MultiCell stock?
You can buy MCET shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MultiCell?
The stock symbol or ticker of MultiCell is MCET.
Which industry does the MultiCell company belong to?
The MultiCell industry is Biotechnology.
How many shares does MultiCell have in circulation?
The max supply of MultiCell shares is 10B.
What is MultiCell Price to Earnings Ratio (PE Ratio)?
MultiCell PE Ratio is now.
What was MultiCell earnings per share over the trailing 12 months (TTM)?
MultiCell EPS is 0 USD over the trailing 12 months.
Which sector does the MultiCell company belong to?
The MultiCell sector is Healthcare.